ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-shot nanofat injection may beat daily hair loss treatments
Disease control Not yet recruitingThis study compares a single injection of nanofat (processed fat) against PRP injections or daily topical minoxidil for treating male and female pattern hair loss. Sixty adults aged 18-50 with confirmed androgenetic alopecia will be enrolled. The goal is to see if nanofat offers …
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated May 26, 2026 07:57 UTC
-
New hair loss pill enters final testing phase
Disease control Not yet recruitingThis study tests an oral medication (N1087, a form of minoxidil) against a placebo in 372 men aged 18 to 60 with moderate male pattern baldness. Participants take a pill once daily for 24 weeks, starting with a low dose that increases over the first 8 weeks. The goal is to see if…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 26, 2026 07:53 UTC